Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
17.54
+0.36 (2.07%)
At close: Jul 24, 2026, 4:00 PM EDT
17.63
+0.09 (0.54%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Trevi Therapeutics Employees
Trevi Therapeutics had 34 employees as of December 31, 2025. The number of employees increased by 8 or 30.77% compared to the previous year.
Employees
34
Change (1Y)
8
Growth (1Y)
30.77%
Revenue / Employee
n/a
Profits / Employee
-$1,341,500
Market Cap
2.49B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 34 | 8 | 30.77% |
| Dec 31, 2024 | 26 | 1 | 4.00% |
| Dec 31, 2023 | 25 | 0 | - |
| Dec 31, 2022 | 25 | 1 | 4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Beam Therapeutics | 522 |
| Vericel | 398 |
| Tarsus Pharmaceuticals | 370 |
| Nurix Therapeutics | 317 |
| Immunome | 206 |
| Pharvaris | 134 |
| Kodiak Sciences | 130 |
TRVI News
- 3 days ago - Serina Therapeutics appoints Trevi Therapeutics CCO Farrell Simon to board - TheFly
- 5 days ago - Trevi Therapeutics initiated with an Outperform at BMO Capital - TheFly
- 5 days ago - Trevi Therapeutics initiated with an Outperform at BMO Capital - TheFly
- 5 days ago - Trevi Therapeutics price target raised to $31 from $21 at B. Riley - TheFly
- 6 days ago - Trevi Therapeutics price target raised to $24 from $21 at H.C. Wainwright - TheFly
- 6 days ago - Trevi Therapeutics price target raised to $40 from $29 at Clear Street - TheFly
- 8 days ago - Trevi Therapeutics rises 10.9% - TheFly
- 8 days ago - Trevi Therapeutics rises 10.4% - TheFly